Blonder Tongue Laboratories Inc (BDRLQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -742 | -1,339 | -384 | -1,195 | -6,771 |
| Depreciation Amortization | 1,263 | 665 | 786 | 972 | 1,308 |
| Income taxes - deferred | N/A | -104 | -35 | 10 | 34 |
| Accounts receivable | 175 | -33 | -348 | 159 | -72 |
| Other Working Capital | -828 | 836 | -1,249 | 396 | 2,317 |
| Other Operating Activity | -6,406 | 562 | 993 | 429 | 2,386 |
| Operating Cash Flow | $-6,538 | $587 | $-237 | $771 | $-798 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 9,527 | -81 | -138 | -37 | -188 |
| Purchase Sale Intangibles | -53 | -20 | -62 | -19 | -453 |
| Other Investing Activity | -53 | -20 | -62 | -19 | -453 |
| Investing Cash Flow | $9,474 | $-101 | $-200 | $-56 | $-641 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 102 | 116 | 367 | -544 | 1,395 |
| Debt Issued | N/A | N/A | N/A | 3,900 | 100 |
| Debt Repayment | -3,032 | -251 | -230 | -3,612 | -279 |
| Common Stock Issued | 7 | 40 | N/A | N/A | N/A |
| Financing Cash Flow | $-2,923 | $-95 | $137 | $-256 | $1,216 |
| Beginning Cash Position | 559 | 168 | 468 | 9 | 232 |
| End Cash Position | 572 | 559 | 168 | 468 | 9 |
| Net Cash Flow | $13 | $391 | $-300 | $459 | $-223 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,538 | 587 | -237 | 771 | -798 |
| Capital Expenditure | -263 | -81 | -138 | -37 | -188 |
| Free Cash Flow | -6,801 | 506 | -375 | 734 | -986 |